623 related articles for article (PubMed ID: 31703822)
1. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
2. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
Roesch S; Rapp C; Dettling S; Herold-Mende C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
[TBL] [Abstract][Full Text] [Related]
3. The Role of Myeloid Cells in GBM Immunosuppression.
Lin YJ; Wu CY; Wu JY; Lim M
Front Immunol; 2022; 13():887781. PubMed ID: 35711434
[TBL] [Abstract][Full Text] [Related]
4. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
[No Abstract] [Full Text] [Related]
5. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
[TBL] [Abstract][Full Text] [Related]
6. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
7. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.
Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS
Cells; 2021 Apr; 10(4):. PubMed ID: 33919732
[TBL] [Abstract][Full Text] [Related]
8. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
Chang AL; Miska J; Wainwright DA; Dey M; Rivetta CV; Yu D; Kanojia D; Pituch KC; Qiao J; Pytel P; Han Y; Wu M; Zhang L; Horbinski CM; Ahmed AU; Lesniak MS
Cancer Res; 2016 Oct; 76(19):5671-5682. PubMed ID: 27530322
[TBL] [Abstract][Full Text] [Related]
9. Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology.
Gutmann DH; Kettenmann H
Neuron; 2019 Nov; 104(3):442-449. PubMed ID: 31697921
[TBL] [Abstract][Full Text] [Related]
10. The controversial role of microglia in malignant gliomas.
Wei J; Gabrusiewicz K; Heimberger A
Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.
Pang L; Khan F; Heimberger AB; Chen P
Trends Cancer; 2022 Oct; 8(10):839-854. PubMed ID: 35624002
[TBL] [Abstract][Full Text] [Related]
12. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy.
Lin C; Wang N; Xu C
Front Immunol; 2023; 14():1123853. PubMed ID: 36969167
[TBL] [Abstract][Full Text] [Related]
13. [The immunosuppressive microenvironment of malignant gliomas].
Borisov KE; Sakaeva DD
Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.
Wurdinger T; Deumelandt K; van der Vliet HJ; Wesseling P; de Gruijl TD
Biochim Biophys Acta; 2014 Dec; 1846(2):560-75. PubMed ID: 25453365
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
[TBL] [Abstract][Full Text] [Related]
16. Molecular interactions between tumor and its microenvironment in malignant gliomas.
Ellert-Miklaszewska A; Pasierbinska M; Poleszak K; Kamińska B
Postepy Biochem; 2018 Oct; 64(2):129-140. PubMed ID: 30656895
[TBL] [Abstract][Full Text] [Related]
17. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
[TBL] [Abstract][Full Text] [Related]
19. Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models.
Alghamri MS; Kamran N; Kadiyala P; Lowenstein PR; Castro MG
Methods Enzymol; 2020; 632():215-228. PubMed ID: 32000897
[TBL] [Abstract][Full Text] [Related]
20. Microglia-glioma cross-talk: a two way approach to new strategies against glioma.
Arcuri C; Fioretti B; Bianchi R; Mecca C; Tubaro C; Beccari T; Franciolini F; Giambanco I; Donato R
Front Biosci (Landmark Ed); 2017 Jan; 22(2):268-309. PubMed ID: 27814616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
